Middle East Pharmaceutical Industries Co.

Last Updated:
  • 59.00 SAR
  • -0.40
  • -0.67%
شركة الشرق الأوسط للصناعات الدوائية
أفالون فارما
Symbol : 4016
ISIN : SA160G51UO10
Day Range : -
Turnover Ratio : 0.65
Market : Saudi Exchange
Sector : Pharma, Biotech & Life Science
Latest Announcements
2026-08-18 05:01:00.0Middle East Pharmaceutical Industries Co. Announces Contract Sign Off with Bio-Thera Solutions Inc. A global biopharmaceutical company specializing in innovative biologics and biosimilars
2026-08-10 05:43:00.0Middle East Pharmaceutical Industries Co. announces the board of director’s decision to distribute cash dividends for the first half of 2026.
2026-08-06 05:03:00.0Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2026-06-30 (Six Months)
2026-05-31 12:45:00.0Middle East Pharmaceutical Industries Co. announces the deposit of the amounts from selling the shares fractions resulted from the company’s capital Increase in the eligible shareholder’s accounts
2026-05-14 05:28:00.0The Securities Depository Center Company (Edaa) Announces Implementing a Corporate Action on Middle East Pharmaceutical Industries Co. Securities

Middle East Pharmaceutical Industries Co. Stock Overview

View Company Profile

Stock Summary

Last Price (SAR) 59.00
Prev. Close 59.400
Day Range 58.60 - 59.90
52WK range
Turnover (M SAR) 4.41
Volume (M) 0.07
Number of Trades 1,283
Market Cap (M SAR) 2,079.00
Change in Market Cap (M SAR)
VWAP (SAR) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M SAR)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
  • No Upcoming Events

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) announced a net profit of SAR 55.70 million for the first half (H1) of...

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) named Ahmad Shaher Al Tabbaa as the board’s Chairman for the next...

Riyadh - Mubasher: The Capital Market Authority (CMA) approved the request of Middle East Pharmaceutical Industries Company (Avalon Pharma) to...

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with...

Riyadh – Mubasher: The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million...